Strategic Restructuring Positions Company to Strengthen Market Presence with Expanded Operational Capabilities

BEIJING, Oct. 24, 2025 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (“Origin” or the “Company”), a leading Chinese agricultural technology company, today announced a series of major milestones designed to enhance its operational capabilities, strengthen its market position, and advance its long-term growth strategy.

Origin Agritech has received a new crop seed production and operation license from the Beijing Municipal Bureau of Agriculture and Rural Affairs, authorizing the Company to produce, process, package, wholesale, and retail corn seeds. This license represents a significant step forward in expanding Origin’s production capacity and operational infrastructure.

With this approval, Origin now holds two crop seed production and operation licenses in China -the other being held by its subsidiary Xinjiang OriginBio Seed Limited – enabling a broader regional footprint and greater revenue diversification across complementary markets.

Additionally, the Beijing Tongzhou District Market Supervision Administration has formally approved the inclusion of genetically modified (GMO) crop seed production in the Company’s business scope. This authorization allows Origin to participate in China’s rapidly evolving GMO seed sector, positioning the Company to capitalize on the increasing adoption of biotechnology in agriculture. Each specific GMO crop will continue to require individual registration and approval prior to commercialization.

In parallel, Origin has increased the registered capital of its subsidiary Beijing Origin Seed Ltd. (“Beijing Origin”) from RMB 30 million (US$4.2 million) to RMB 100 million (US$14 million). The Company has also completed a strategic restructuring, consolidating its key production and sales entities — including Xinjiang Originbo Seed Limited — under Beijing Origin. This integration establishes Beijing Origin as the Company’s primary operational hub, enhancing efficiency and supporting future scalability.

These initiatives collectively strengthen Origin’s capacity to serve the vital North China Plain agricultural region and beyond. The capital increase provides additional financial flexibility for investments in research and development, product innovation, and market expansion, supporting Origin’s mission to deliver next-generation agricultural solutions.

Weibin Yan, Chief Executive Officer of Origin Agritech, commented, “Today’s announcements mark a transformative step for Origin Agritech. The addition of our new GMO-inclusive business license, combined with the successful capital increase and organizational restructuring, provides a powerful infrastructure for our next phase of growth. By consolidating our research, breeding, seed production and sales network strengths under Beijing Origin, we are streamlining our operations, accelerating innovation, and positioning ourselves to bring our advanced seed technologies — including our GMO pipeline — to market more efficiently. These strategic moves reinforce our commitment to delivering value for both farmers and shareholders.”

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered at the Origin R&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech’s phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China’s Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and Bt (pest resistance) traits. For further information, please visit the Company’s website at www.originagritech.com. The Company also maintains an X account to update investors on company and industry developments, which is https://x.com/origin_agritech.

Forward-Looking Statements

This communication contains “forward-looking statements” as defined in the federal securities laws, including Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements address expected future business and financial performance and financial condition and contain words like “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “will,” “would,” “target,” and similar expressions and variations. Forward-looking statements address matters that are uncertain. Forward-looking statements are not guarantees of future performance and are based on assumptions and expectations that may not be realized. They are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates but involve a number of risks and uncertainties, many of which are beyond the Company’s control. Some of the important factors that could cause the Company’s actual results to differ materially from those discussed in forward-looking statements are: failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting our products; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; natural disasters and weather events and patterns; ability to protect and enforce the Company’s intellectual property rights; and separation of underperforming or non-strategic assets or businesses. The Company undertakes no duty or obligation to publicly revise or update any forward-looking statements as a result of future developments, new information, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure that such expectations will be correct. Actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein. You are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.

For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com  

Groundbreaking Human-Centric Genomic Foundation Model Unveiled

HANGZHOU, China, Oct. 24, 2025 /PRNewswire/ — The future of Omics and AI in life sciences is the central theme for more than 100 scientists and guests from 19 countries and regions gathered in Hangzhou, China, for the 20th Annual Meeting of the International Conference on Genomics (ICG-20) this week.

Discussions will span global collaboration in omics and AI, cancer genomics, biodiversity and multi-omics of deep-sea organisms, metagenomics and epidemiology, public health and precision medicine, and the transformative potential of AI in healthcare and across life sciences.

At the opening session, BGI-Research and Zhejiang Lab jointly unveiled Genos, an open-source, human-centric genomic foundation model with over 10 billion parameters. This breakthrough paves the way for individuals to easily interpret their own genomic information, fueling advancements in clinical disease diagnosis, personalized medicine, and transformative scientific discoveries.

Delivering the opening address, Professor Huanming Yang, Academician of the Chinese Academy of Sciences, Co-founder and Member of the Board of Directors of BGI Group, and Chair of the ICG-20 Organizing Committee, reflected on the critical role of global collaboration in driving progress across the field of genomics.

Among the speakers on the first day, Dr. George Church, a member of the U.S. National Academy of Sciences, National Academy of Engineering, and American Academy of Arts and Sciences, and Professor at Harvard Medical School, shared the latest advancements in the integration of omics and AI research.

Dr. James Crabbe, Fellow of Wolfson College at the University of Oxford, showcased how omics technologies and AI are transforming future medicine, ecology, and agriculture.

Dr. Jian Wang, Academician of the Chinese Academy of Engineering, Director of Zhejiang Lab, outlined the profound impact of open-source innovation and explained how AI, when integrated with science, is emerging as a fundamental tool for scientific discovery.

In addition, Dr. Hefeng Huang, Academician of the Chinese Academy of Sciences and Dean of the International School of Medicine, Zhejiang University, presented her latest research on leveraging omics technologies for the early prevention of ovarian and breast cancer.

Over the past 20 years, ICG has embodied the collaborative spirit of the Human Genome Project, “Owned by All, Done by All, and Shared by All”. ICG remains committed to serve as a vital nexus for connecting international scientific efforts and promoting progress in life sciences.

SHANGHAI, Oct. 24, 2025 /PRNewswire/ — Lanvin Group (NYSE: LANV), a global luxury fashion group, today announced the appointment of Mr. Jiyang Han as Chief Financial Officer (CFO) of the Company, effective November 1, 2025. In this role, Mr. Han will oversee the Group’s financial affairs, including financial planning and analysis, accounting and controllership, financial management, treasury, investment and financing projects, and investor relations. 

Mr. Han brings nearly two decades of experience in corporate finance, investment banking, and global business management. He has served as Co-CIO and Assistant President of Yuyuan (SHSE: 600655) since June 2025. Prior to that, he was the M&A and Strategy Leader, Greater China at 3M Company (NYSE: MMM). From 2011 to 2019, he was heading Ivory Capital’s Investment Banking team in Greater China. Earlier in his career, he worked as CPA and Senior Consultant at Ernst & Young China.

Mr. Han holds a Bachelor of Commerce degree in Accounting from the University of British Columbia.

Mr. Zhen Huang, Chairman of Lanvin Group, said, “We are delighted to welcome Jiyang to Lanvin Group’s executive leadership team. His extensive experience in financial strategy, global M&A, and capital market will be invaluable as we continue to strengthen our financial discipline and support the Group’s growth ambitions worldwide. His appointment reflects our continued commitment to building a strong, future-ready organization.”

Mr. Han commented, “I am honored to join Lanvin Group at such a pivotal moment in its journey. The Group’s vision, global brand portfolio, and commitment to sustainable value creation are truly inspiring. I look forward to working closely with the leadership team to further enhance our financial capabilities and drive long-term growth for our shareholders and partners.”

Mr. Han succeeds Mr. David Chan, whose planned departure as Executive President and CFO was previously announced and will take effect on October 27, 2025.

About Lanvin Group

Lanvin Group is a leading global luxury fashion group headquartered in Shanghai, China and Milan, Italy, managing iconic brands worldwide including Lanvin, Wolford, Sergio Rossi, St. John Knits, and Caruso. Harnessing the power of its unique strategic alliance of industry-leading partners in the luxury fashion sector, Lanvin Group strives to expand the global footprint of its portfolio brands and achieve sustainable growth through strategic investment and extensive operational know-how, combined with an intimate understanding and unparalleled access to the fastest-growing luxury fashion markets in the world. Lanvin Group is listed on the New York Stock Exchange under the ticker symbol “LANV”. For more information about Lanvin Group, please visit www.lanvin-group.com, and to view our investor presentation, please visit https://ir.lanvin-group.com. 

Enquiries:
Media
Lanvin Group
Winni Ren
winni.ren@lanvin-group.com 

Investors
Lanvin Group
Coco Wang
coco.wang@lanvin-group.com 

SINGAPORE, Oct. 24, 2025 /PRNewswire/ — China Yuchai International Limited (NYSE: CYD) (“China Yuchai” or the “Company”), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery Company Limited (“Yuchai”), announced that its subsidiary Yuchai Marine and Genset Power Company Limited successfully launched its new YC16VTF engine at the National Engineering Research Center.  The launch of this new-generation 16-cylinder V-type power generation engine demonstrates another major breakthrough for Yuchai in the field of high-speed, high-horsepower (“HHP”) engines.  This new performance-enhancing HHP engine clearly demonstrates Yuchai’s determination to lead the high-end marine and power generation markets in China.

Rising global demand for computing power and data centers is being met partially through innovative power generation technology.  An evolving trend toward higher reliability, enhanced energy conservation and environmental protection, higher intelligence, larger-scale power and diversified power distribution, requires new technological approaches. The development of a new generation of HHP engines became an urgent industry need.

The Yuchai YC16VTF engine utilizes innovative industry-leading design concepts, achieving dual technological breakthroughs in high strength and reduced weight.  With a maximum power output of 3,971kW, it meets the application requirements for high-end 50Hz/60Hz generator sets. With its serialized and modular design, this engine can be expanded to a variety of applications in the future. 

Mr. Weng Ming Hoh, President of China Yuchai, commented, “The launch of the YC16VTF engine is consistent with Yuchai’s goal of growing as a high-end brand with high performance and reliability standards.”

“The YC16VTF engine sets new performance records for Yuchai in HHP engines, enriching its power engine portfolio of product offerings. This new engine is another important milestone in Yuchai’s active response to the national ‘dual carbon’ strategy and its promotion of the green industrial transformation,” Mr. Hoh concluded.

About China Yuchai International

China Yuchai International Limited, through its subsidiary Guangxi Yuchai Machinery Company Limited (“Yuchai”), is one of the leading powertrain solution providers in China. Yuchai specializes in the design, manufacture, assembly, and sale of a wide variety of light-, medium- and heavy-duty engines for trucks, buses, pickups, construction and agricultural equipment, and marine and power generation applications. Yuchai offers a comprehensive portfolio of powertrain solutions, including but not limited to diesel, natural gas, and new energy products such as pure electric, range extenders, and hybrid and fuel cell systems.  Through its extensive network of regional sales offices and authorized customer service centers, Yuchai distributes its engines directly to auto OEMs and distributors while providing after-sales services across China and globally.  Founded in 1951, Yuchai has established a reputable brand name, built a strong research and development team, and achieved a significant market share in China. Known for its high-quality products and reliable after-sales support, Yuchai has also expanded its footprint into overseas markets.  In 2024, Yuchai sold 356,586 engines, further solidifying its position as a leading manufacturer and distributor of engines in China.  For more information, please visit http://www.cyilimited.com. 

Safe Harbor Statement:

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “expect”, “anticipate”, “project”, “targets”, “optimistic”, “confident that”, “continue to”, “predict”, “intend”, “aim”, “will” or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that may be deemed forward-looking statements. These forward-looking statements, including, but not limited to, statements concerning China Yuchai’s and the joint ventures’ operations, financial performance and condition, are based on current expectations, beliefs and assumptions which are subject to change at any time. China Yuchai cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors such as government and stock exchange regulations, competition, political, economic and social conditions around the world and in China, including those discussed in China Yuchai’s Form 20-Fs under the headings “Risk Factors”, “Results of Operations” and “Business Overview” and other reports filed with the Securities and Exchange Commission from time to time. All forward-looking statements are applicable only as of the date they are made and China Yuchai specifically disclaims any obligation to maintain or update the forward-looking information, whether of the nature contained in this release or otherwise, in the future.

For more information:

Investor Relations
Kevin Theiss
Tel: +1-212-510-8922
Email: cyd@bluefocus.com